Lifeline Cell Technology

Headquarters

Frederick, MD

UEI

TVSAANLAZFY3

CAGE

4QA16

Lifeline Cell Technology develops and manufactures purified primary human cells, stem-cell products, and optimized cell-culture media for laboratory research. Its founders helped introduce normal human cell systems more than 25 years ago, and the company now operates an 8,000-square-foot laboratory and administrative facility in Frederick, Maryland as a wholly owned subsidiary of International Stem Cell Corporation. Lifeline also supports researchers through scientist-led technical assistance and an international distributor network.

• STEMCELL TechnologiesFounded in 1993 by hematopoietic stem-cell researcher Dr. Allen Eaves, STEMCELL Technologies grew from his effort to produce standardized, cost-effective cell culture media into a global biotechnology company. Based in Vancouver and guided by its “Scientists Helping Scientists” ethos, the company supports life-science researchers worldwide with tools and expert assistance for cell-based research. Its quality management system is certified to ISO 13485:2016 and ISO 9001:2015.HARLEYSVILLE, PA
• RE
  REPROCELL IncEstablished in Japan in 2003 by researchers from Kyoto University and the University of Tokyo, REPROCELL is a biotech company built around pioneering work with human embryonic and induced pluripotent stem cells. It became an early commercial supplier of iPSC-derived human cells and now supports scientists and therapy developers with stem-cell research and clinical development services.BELTSVILLE, MD
• BioSpherix, LLCFor more than 30 years, BioSpherix has been known for putting the needs of living cells at the center of laboratory design. The Parish, New York biotechnology company develops controlled environments for researchers and biomanufacturers, with its work cited in thousands of peer-reviewed publications worldwide.PARISH, NY
• Elk BioscienceElk Bioscience makes clinical-grade pooled human platelet lysate, a xeno-free cell-culture supplement for research, regenerative medicine and cell-therapy manufacturing. Based at the Pennsylvania Biotechnology Center in Doylestown, the company produces its hPL in a proprietary GMP facility using platelet units that would otherwise have been discarded, pooling material from more than 200 U.S. donors to reduce lot-to-lot variation. Its products are GMP compliant, heparin-free and supported by an FDA Data Master File for clinical-trial use.DOYLESTOWN, PA